Thoratec, the Thoratec logo, HeartMate, and HeartMate II are registered trademarks of Thoratec Corporation, and IVAD is a trademark of Thoratec Corporation. ITC, A-VOX Systems, AVOXimeter, HEMOCHRON, ProTime, and IRMA are registered trademarks of International Technidyne Corporation. CentriMag is a registered trademark of Levitronix LLC.
Many of the preceding paragraphs, particularly but not exclusively
those addressing guidance for fiscal 2008 financial results, future
performance or timelines and milestones for clinical trials, contain
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange Act of
1934. These statements can be identified by the words, "believes," "views,"
"expects," "projects," "hopes," "could," "will," and other similar words.
Actual results, events or performance could differ materially from these
forward-looking statements based on a variety of factors, many of which are
beyond Thoratec's control. Therefore, readers are cautioned not to put
undue reliance on these statements. Investors are cautioned that all such
statements involve risks and uncertainties, including risks related to the
development of new markets including Destination Therapy, the growth of
existing markets for our products, customer and physician acceptance of
Thoratec products, changes in the mix of existing markets for our products
and related gross margin for such product sales, the results of enrollment
in and timing of clinical trials, including for the HeartMate II, the
ability to improve financial performance, regulatory approval processes,
the effects of healthcare reimbursement and coverage policies, the effects
of seasonality in Thoratec product sales, the effects of price competition
from any Thoratec competitors and the effects of any merger
|SOURCE Thoratec Corporation|
Copyright©2008 PR Newswire.
All rights reserved